HeyJaredArthur Allen
- Indexed articles, last 90 days
- 1
- Latest publication
- Aug 19, 2026
- Outlet visibility, for CNN
- Top 1K sites
- Earliest in this view
- Aug 19, 2026
Latest articles
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages | CNN (opens the original)
Read excerpt
Northwestern University economist Chuck Manski studies decision-making amid uncertainty. That prepared him better than many other cancer patients to decide whether to stay on an immunotherapy treatment that was making him very ill. For six months in 2022, Manski received monthly infusions of nivolumab to fight advanced melanoma. The drug ruined his thyroid gland, he said, requiring him to go on a special medication for the rest of his life, and caused severe dryness in his eyes, lips, and mouth.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For CNN, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.